Submitted by PatientsEngage on 28 March 2022

This webinar is not just for Ovarian Cancer survivors but also for survivors of breast cancer, uterine cancer, colorectal cancer and all women at risk of Ovarian Cancer.

Ovarian Cancer is a difficult to diagnose cancer. So it is very important for us to be aware of the surprising symptoms of Ovarian cancer. We must also know the factors that increase risk.
Additionally, in COVID times, it is important to understand how to continue treatment and when you should vaccinate.

We bring together a panel of
Dr. Shyam Aggarwal, Chairman Medical Oncology, Sir Gangaram Hospital, New Delhi
Dr. Nidhi Tandon, Consultant Medical Oncology Narayana Health, Bengaluru
Dr. Vivek Agarwala, Medical Oncologist, Narayana Superspeciality Hospital, Kolkata

In the video (recording link below) we talk about:

  • What is ovarian cancer and who is at risk of ovarian cancer? is it hereditary
  • What are the early signs or symptoms of ovarian cancer?
  • Who should you consult when you have symptoms
  • What is the difference between cyst and cancer and how to differentiate between the two
  • Does removal of ovaries reduce lifespan?
  • What are the treatment options after diagnosis of ovarian cancer?
  • What risks should patients be aware of and role of chemo before or after surgery
  • If you have ovarian cancer can you also get breast cancer?
  • Even during covid cancer treatment cannot be postponed
  • Are video consults useful
  • Can cancer patients undergo Covid vaccination

 

Community
Women's Health and Pregnancy
Cancer
Condition
Breast Cancer
Cancer
Endometriosis
Ovarian Cancer
Uterine Fibroids

Stories

  • Image shows a woman looking at a strip of medicines
    Are Birth Control Pills Safe?
    Dr Shital Patel answers all that you want to know about oral contraceptives, how they work, when you should use them, side effects, do they increase the risk of cancer? What are Oral Contraceptives? Oral contraceptives are hormonal preparations that may contain progesterone or combination of oestrogen and progestin. The combination drug prevents pregnancy by inhibiting the release of the hormones - luteinizing hormone (LH) and follicle stimulating hormone (FSH) from the pituitary…
  • Treating breast cancer while sparing the heart
    The difference between conventional X-ray therapy and proton therapy – and why we are re-examining the way we treat left-side breast cancer.  The majority of breast cancer patients today are able to preserve their breasts as they undergo a lumpectomy followed by post-operative radiation. However, research shows that left-side breast cancer patients treated with radiation have an increased risk of radiation-induced heart problems. Here, Dr. Brian Chon writes about the connection…
  • A significant number of cancer patients are treated by non-specialists
    On the occasion of World Cancer Day, Dr V Shanta, Chairperson of Adyar Cancer Institute, Chennai, a doyenne in her field, talks to PatientsEngage about the challenges of tackling cancer in India. “India has state of the art facilities but it does not reach everyone.”  PE: There are many differing views on how frequently one should have mammograms. You have said that annual mammograms are unnecessary.  Dr. Shanta: I believe that we do follow the general guidelines laid…
  • The Jonathan Dimbleby doctrine: You don’t beat cancer by not talking about it
    Broadcaster Jonathan Dimbleby – son of a BBC legend – tells Charlie Cooper how his father’s candour informed the family’s attitude to coping with illness Britain in 1965 was not a country that talked about cancer. So when one of the most recognisable men in Britain, the veteran broadcaster Richard Dimbleby, decided in October 1965 to go public with the fact that he was suffering from it, the announcement stunned the country. “The newspapers, when he said: ‘I have got cancer’, responded…
  • FDA approves Ibrance for postmenopausal women with advanced breast cancer
    The U.S. Food and Drug Administration today granted accelerated approval to Ibrance (palbociclib) to treat advanced (metastatic) breast cancer. Breast cancer in women is one of the three common cancers in most countries.  The drug, whose chemical name is palbociclib, was approved for previously untreated postmenopausal women whose cancer cells have receptors to the female hormone estrogen and who do not have mutations in the HER2 gene that can contribute to uncontrolled growth of breast…
  • Sugary drinks linked to earlier onset of menstrual periods and higher risk of breast cancer
    Girls who frequently consume sugary drinks tend to start their menstrual periods earlier than girls who do not, according to new research published online Jan 28 in Human Reproduction. This effect was independent of the girls' body mass index (BMI), height, total food intake and other lifestyle factors such as physical activity. The findings are important not only because of the growing problem of childhood obesity in a number of developed countries, but also because starting periods earlier is…
  • Don't Believe the Hype - 10 Persistent Cancer Myths Debunked
    Driven by the evidence, not by rhetoric or anecdote, we describe what the reality of research actually shows to be true. Myth 1: Cancer is a man-made, modern disease While it’s certainly true that global lifestyle-related diseases like cancer are on the rise, the biggest risk factor for cancer is age. Myth 2: Superfoods prevent cancer Blueberries, beetroot, broccoli, garlic, green tea… the list goes on. Despite thousands of websites claiming otherwise, there’s no such thing…
  • Cambridge University finds gene behind killer disease - Triple negative breast cancer
    Triple-negative breast cancer is one of the most deadly forms of the disease, does not respond to hormonal therapies such as tamoxifen, or targeted drugs like Herceptin and nearly one quarter of patients diagnosed will not survive for more than five years. Now researchers at Cambridge University and the Wellcome Trust’s Sanger Institute have found that the BCL11A gene is overactive in eight out of ten patients. The study opens the door for therapies which suppress the gene and…
  • Goodbye Year of Cancer. Hello Hope!
    Death stared at me up close this year, says cancer survivor Minakshi Ray. What did that teach her about life? As I sit back and take stock of how 2014 treated me, I would say, it was a mixed bag. There have been losses and gains. I don't mean material losses or gains, rather I will remember the year in terms of the emotional journey. Following my battle of survival against breast cancer, my perspective on life has changed completely. The biggest realisation that has dawned…
  • Ovarian cancer
    What is ovarian cancer Ovarian cancer is cancer that develops in one or both the ovaries. It can then spread to other parts of the body. Cancer in the ovaries can also be a secondary cancer, the result of metastasis from a primary cancer elsewhere in the body. 7% of ovarian cancers are due to metastases while the rest are primary cancers that occur in the ovaries itself. Cancer occurring primarily in breast or in gastrointestintinal tract most often tend to metastasise to the ovaries. Ovarian…